Tags

Type your tag names separated by a space and hit enter

[Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease].
Urologiia. 2006 Jul-AugU

Abstract

Twenty nine patients with neurogenic detrusor overactivity due to Parkinson's disease have undergone percutaneous tibial neuromodulation. The treatment consisted of percutaneous insertion of a 34-gauge solid stainless steel needle at a point of 5 cm cephald from the medial malleolus. The patients were treated weekly for 30 minutes. A subjective effect was assessed using a dairy and I-PSS score. Objective results were evaluated by cystometry. We observed a decrease in the average voiding frequency, number of leakage episodes after 12 sessions and 6 months of the tibial neuromodulation. An over 50% symptomatic improvement was achieved in 26 of 29 patients including 6 patients who were refractory to anticholinergic agents and 9 men with benign prostatic hyperplasia. Tibial neuromodulation is an effective treatment in patients with neurogenic detrusor overactivity due to Parkinson's disease.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
English Abstract
Journal Article

Language

rus

PubMed ID

17058670

Citation

Krivoborodov, G G., et al. "[Tibial Neuromodulation in the Treatment of Neurogenic Detrusor Hyperactivity in Patients With Parkinson's Disease]." Urologiia (Moscow, Russia : 1999), 2006, pp. 3-6.
Krivoborodov GG, Gekht AB, Korshunova ES. [Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease]. Urologiia. 2006.
Krivoborodov, G. G., Gekht, A. B., & Korshunova, E. S. (2006). [Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease]. Urologiia (Moscow, Russia : 1999), (4), 3-6.
Krivoborodov GG, Gekht AB, Korshunova ES. [Tibial Neuromodulation in the Treatment of Neurogenic Detrusor Hyperactivity in Patients With Parkinson's Disease]. Urologiia. 2006 Jul-Aug;(4)3-6. PubMed PMID: 17058670.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Tibial neuromodulation in the treatment of neurogenic detrusor hyperactivity in patients with Parkinson's disease]. AU - Krivoborodov,G G, AU - Gekht,A B, AU - Korshunova,E S, PY - 2006/10/25/pubmed PY - 2006/11/14/medline PY - 2006/10/25/entrez SP - 3 EP - 6 JF - Urologiia (Moscow, Russia : 1999) JO - Urologiia IS - 4 N2 - Twenty nine patients with neurogenic detrusor overactivity due to Parkinson's disease have undergone percutaneous tibial neuromodulation. The treatment consisted of percutaneous insertion of a 34-gauge solid stainless steel needle at a point of 5 cm cephald from the medial malleolus. The patients were treated weekly for 30 minutes. A subjective effect was assessed using a dairy and I-PSS score. Objective results were evaluated by cystometry. We observed a decrease in the average voiding frequency, number of leakage episodes after 12 sessions and 6 months of the tibial neuromodulation. An over 50% symptomatic improvement was achieved in 26 of 29 patients including 6 patients who were refractory to anticholinergic agents and 9 men with benign prostatic hyperplasia. Tibial neuromodulation is an effective treatment in patients with neurogenic detrusor overactivity due to Parkinson's disease. SN - 1728-2985 UR - https://www.unboundmedicine.com/medline/citation/17058670/[Tibial_neuromodulation_in_the_treatment_of_neurogenic_detrusor_hyperactivity_in_patients_with_Parkinson's_disease]_ L2 - https://medlineplus.gov/urinaryincontinence.html DB - PRIME DP - Unbound Medicine ER -